Hopp til innhold
NHI.no
Annonse

Diabetes og magekomplikasjoner: Forandringer i spiserøret

Innhold i artikkelen

Unormale sammentrekninger (peristaltikk) i spiserøret og svekket lukkemuskel på overgangen mellom spiserøret og magesekken kan føre til plager i form av brystbrann og svelgevansker (refluksplager). Slike symptomer oppstår imidlertid kun hos en minoritet av pasienter med diabetes. Andre mulige faktorer som bidrar til refluksplager ved diabetes, er fedme, høyt blodsukker og nedsatt utskillelse av bikarbonat (som nøytraliserer syre) fra spyttkjertlene.

Behandlingen består i god blodsukkerkontroll og medikamenter mot refluks.

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Diabetes, gastrointestinale kompl . Referanselisten for dette dokumentet vises nedenfor

  1. Careyva B, Stello B. Diabetes Mellitus: Management of Gastrointestinal Complications. Am Fam Physician. 2016;94(12):980-986. PubMed
  2. Frieling T. Diabetic autonomic neuropathy of the gastrointestinal tract. UpToDate, last updated Aug 07, 2018. www.uptodate.com
  3. Stein B, Everhart KK, Lacy BE. Gastroparesis: A review of current diagnosis and treatment options. Journal of Clinical Gastroenterology, August 2015 ; 49: 550-8. doi:10.1097/MCG.0000000000000320 DOI
  4. Ebert EC. Gastrointestinal complications of diabetes mellitus. Dis Mon 2005; 51: 620-63. PubMed
  5. Bharucha AE. Epidemiology and natural history of gastroparesis. Gastroenterol Clin North Am. 2015;44(1):9–19. PMID: 25667019 PubMed
  6. Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L; American College of Gastroenterology. Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2013;108(1):18–37. PMID: 23147521 PubMed
  7. Galligan JJ, Vanner S. Basic and clinical pharmacology of new motility promoting agents. Neurogastroenterol Motil 2005; 17: 643-53. PubMed
  8. Hejazi RA, McCallum RW, et al. Prokinetics in diabeetic gastroparesis. Curr Gastroenterol Rep 2012; 14: 297-305. PubMed
  9. Ramirez R, Stalcup P, Croft B, Darracq MA. Haloperidol undermining gastroparesis symptoms (HUGS) in the emergency department. Am J Emerg Med 2017. pmid:28320545 PubMed
  10. Olausson EA, Storsrud S, Grundin H, et al. A Small Particle Size Diet Reduces Upper Gastrointestinal Symptoms in Patients With Diabetic Gastroparesis: A Randomized Controlled Trial. Am J Gastroenterol 2014 Jan 14.
  11. Anand C, Al-Juburi A, Familoni B, et al. Gastric electrical stimulation is safe and effective: a long-term study in patients with drug-refractory gastroparesis in three regional centers. Digestion 2007; 75: 83-9. PubMed
  12. Boland BS, Edelman SV, Wolosin JD. Gastrointestinal complications of diabetes. Endocrinol Metab Clin North Am. 2013;42(4):809–832. PMID: 24286951 PubMed
  13. Hazlehurst JM, Woods C, Marjot T, Cobbold JF, Tomlinson JW. Non-alcoholic fatty liver disease and diabetes. Metabolism. 2016;65(8):1096–1108. PMID: 26856933 PubMed
  14. Goodwin G. Type 1 Diabetes Mellitus and Celiac Disease: Distinct Autoimmune Disorders That Share Common Pathogenic Mechanisms. Horm Res Paediatr. 2019;92(5):285-292. PubMed
  15. Zein CO, et al. Chronic hepatitis C and type II diabetes mellitus: a prospective cross-sectional study. Am J Gastroenterol 2005; 100: 48-55. PubMed
  16. Lee WG, Wells CI, McCall JL, Murphy R, Plank LD. Prevalence of diabetes in liver cirrhosis: A systematic review and meta-analysis. Diabetes Metab Res Rev. 2019;35(6):e3157. PubMed
  17. Creighton Mitchell T, McClain DA. Diabetes and hemochromatosis. Curr Diab Rep. 2014;14(5):488. PubMed
Annonse
Annonse